Carl Icahn Sells Biogen Idec (BIIB) Shares
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Join SI Premium – FREE
In 13D filing after the close, Carl Icahn disclosed the sale of some Biogen Idec Inc. (Nasdaq: BIIB) shares.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) PT Lowered to $222 at Morgan Stanley
- FDA clears Merck's Keytruda combo for muscle-invasive bladder cancer
- Biogen (BIIB) PT Raised to $242 at RBC Capital
Create E-mail Alert Related Categories
13Ds, Hedge FundsRelated Entities
Carl Icahn, 13DSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
